On this week’s Tech Nation, Moira speaks with Jamie Susskind about his book, “The Digital Republic … On Freedom and Democracy in the 21st Century”. Then, in Biotech, a potential successor to stem cells - fibroblasts? Yes, fibroblasts. Dr. Hamid Khoja, Chief Scientific Officer of FibroBiologics in Houston, describes their fibroblast programs in such diverse conditions as Degenerative Disk Disease, Multiple Sclerosis and Diabetic Foot Ulcers.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
